What a batch manufacturing record is
A batch manufacturing record (BMR) is the document that shows how one specific batch of a product was made. It records which materials went in, which equipment was used, who did each step, what was measured, and whether anything went wrong. When a quality unit decides whether to release a batch, the BMR is the main evidence it reviews.
The terms vary by region and company:
| Term | Where it is used | Meaning |
|---|---|---|
| Batch production and control record | 21 CFR 211.188 (US) | The executed record for each batch |
| Master production and control record | 21 CFR 211.186 (US) | The approved template the batch record is built from |
| Batch processing record | EU GMP Chapter 4, section 4.20 | The executed manufacturing record |
| Batch packaging record | EU GMP Chapter 4, section 4.21 | The executed packaging record |
| Manufacturing formula and processing instructions | EU GMP Chapter 4, sections 4.17 and 4.18 | The EU equivalent of the master record |
| BMR / BPR | Common industry shorthand | Batch manufacturing record / batch production record |
Whatever the label, there are always two layers: an approved master that says what should happen, and an executed record that shows what did happen. Most BMR problems come from a gap between the two.
The master record: what the BMR is built from
Under 21 CFR 211.186(a), master production and control records must be prepared, dated and signed by one person and independently checked, dated and signed by a second person. Section 211.186(b) lists what they must include. The key elements are:
- Product name, strength and dosage form
- Name and weight or measure of each active ingredient per dosage unit
- A complete list of components, with any special notes
- An accurate statement of the quantity of each component
- Theoretical weights or measures at each appropriate phase
- A statement of theoretical yield, “including the maximum and minimum percentages of theoretical yield beyond which investigation according to § 211.192 is required”
- Container, closure and labeling descriptions, with signed specimens of labeling
- Complete manufacturing and control instructions, sampling and testing procedures, specifications, special notations and precautions
EU GMP Chapter 4 covers the same ground. Section 4.17 requires a manufacturing formula listing “all starting materials to be used, with the amount of each,” plus the expected final yield with acceptable limits. Section 4.18 requires “detailed stepwise processing instructions,” including critical process parameters, in-process controls with limits, line clearance checks and equipment preparation.
If the master is vague, the executed record will be too. In the May 2026 warning letters summarized by ECA, one firm’s master records lacked instructions for “speed, time, and the order of component addition.” Operators cannot record compliance with a parameter that was never defined.
What the executed BMR must contain
Section 211.188 requires a batch record for each batch, starting with an accurate reproduction of the master record that has been checked for accuracy, dated and signed. It must then document each significant step. Grouped by purpose, the required content looks like this:
Identity and traceability
- Product name and batch number
- Batch numbers of each component and in-process material used
- Identity of individual major equipment and lines
Execution
- Dates (and, in the EU, times) of each significant step
- Weights and measures of components used
- In-process and laboratory control results
- Inspection of packaging and labeling areas before and after use
Outcome
- Actual yield and percentage of theoretical yield at appropriate phases
- Complete labeling control records, including specimens or copies of all labeling used
- Description of containers and closures
- Any sampling performed
Accountability
- Identification of the people performing and directly supervising or checking each significant step
- Any investigation made under 211.192
- Results of examinations made under 211.134 (labeling and packaging inspection)
EU section 4.20 adds explicit requirements for the time of each step, the initials of the operator and checker, and “signed authorisation for any deviation from the Manufacturing Formula and Processing Instructions.” It ends with approval by the person responsible for the processing operations. For packaging, section 4.21 requires reconciliation of printed packaging materials used, destroyed or returned, “to provide for an adequate reconciliation.”
A practical BMR structure
The regulations list content, not layout. A structure that works for most solid and liquid dose products:
- Header: product, strength, batch number, batch size, master record version, issue date and the name of the person who issued the copy.
- Pre-production: line clearance, room and equipment status, cleaning records referenced, calibration status of balances.
- Material dispensing: each component with lot number, required and actual quantity, performer and checker.
- Processing steps: one block per step, with the instruction, critical parameters, recorded values, limits, time stamps, performer and checker.
- In-process controls: test, limit, result, analyst, and the action taken if a result is out of limit.
- Yield and reconciliation: theoretical yield, actual yield, percentage, limits and a prompt to raise an investigation if outside them.
- Packaging and labeling: line clearance, label issuance and reconciliation, specimens attached.
- Deviations and comments: every deviation number referenced, with status at the time of review.
- Review and approval: production review sign-off, then quality unit review and disposition.
Put limits next to the field where the value is entered. A reviewer should never have to go to another document to know whether a value is acceptable.
The errors inspectors find most often
FDA data and recent warning letters show the same BMR problems year after year.
No record, or an incomplete one. One firm in the May 2026 ECA summary told the investigator that “there was not a batch record for each batch.” Another released product whose batch records showed “no test results” for the active ingredient.
Records not reviewed before release. Section 211.192 was cited in 164 FDA Form 483 observations in FY2025, per GMP Insiders’ analysis of FDA data. In the same data, 211.22(d), on quality unit procedures, drew 243.
Yields outside limits with no investigation. Section 211.192 says unexplained discrepancies, including yields outside the master record limits, must be “thoroughly investigated, whether or not the batch has already been distributed.” A yield recorded as 91% against a 95–102% range, with no investigation number, is a finding.
Missing “checked by” signatures. Section 211.188(b)(11) requires identification of who directly supervised or checked each significant step, including steps done by automated equipment.
Uncontrolled copies. If the record cannot show which master version was issued and when, an inspector cannot confirm the batch was made to the approved process.
Label reconciliation gaps. Mismatches between labels issued, used and destroyed with no explanation are a frequent packaging finding and a recall risk.
Corrections that hide the original. Overwritten entries, correction fluid and unsigned changes break both 211.188 and good documentation practice.
BMR quality checklist
- Master record approved by two signatures and the current version is issued
- Issued copy is traceable (version, issue date, issuer)
- Every 211.188(b) / EU 4.20 element has a field
- Limits are printed next to each recorded value
- Yield limits are defined and trigger an investigation prompt
- Performer and checker are recorded for each significant step
- Label issuance, use and destruction reconcile
- Every deviation is referenced with its status
- Corrections are single-line, dated, signed and explained
- Production and quality unit review are both signed before disposition
Check your batch records with AskDona
BMR review is slow because the reviewer has to hold the master record, the executed record and the deviation log in mind at once. AskDona reads all three and flags missing fields, values outside limits, absent checker signatures, unexplained yield variances and unreferenced deviations, each linked to the page it came from. Run a sample batch record assessment on one of your completed BMRs. AskDona shows the evidence; your quality unit decides.
FAQ
What is the difference between a batch manufacturing record and a batch production record? Nothing in substance. “Batch production and control record” is the FDA term in 211.188. “Batch manufacturing record” and “batch processing record” are common in Europe and Asia.
What is the difference between a master record and a batch record? The master record (211.186) is the approved template. The batch record (211.188) is the filled-in copy for one batch.
How long must batch records be kept? In the US, at least one year after the batch expiry date under 211.180(a), with longer periods for some OTC products. EU rules differ; check Chapter 4 and Annex 16 for your product type.
Who reviews a batch manufacturing record? Production reviews it first. In the US the quality control unit must review and approve it before release (211.192). In the EU it must be available to the Qualified Person, who certifies the batch.
Can a BMR be electronic? Yes, if the system meets 21 CFR Part 11 in the US and Annex 11 in the EU. See our guide to electronic batch records.
References
All pages opened and checked by October 14, 2026.
| Source | Type | Used for |
|---|---|---|
| 21 CFR Part 211 Subpart J (eCFR) | US regulation | 211.180, 211.186, 211.188 and 211.192 |
| EudraLex Volume 4, Chapter 4: Documentation (2011) | EU GMP guideline (copy hosted by ECA) | Sections 4.17, 4.18, 4.20, 4.21 |
| ECA, Five new Warning Letters – Four Batch Record Review Citations | Industry news (May 2026) | Warning letter examples |
| ECA, Batch Record: who needs to review? | Industry news | Production, QC and QP review roles |
| GMP Insiders, FY2025 FDA inspection observations | Industry analysis of FDA data | 211.192 and 211.22(d) citation counts |
| EC consultation on Chapter 4, Annex 11 and Annex 22 (2025) | EU consultation page | Chapter 4 revision status |